CareDx, Inc.
Feb 7, 2018

CareDx to Participate in Upcoming Investor Conferences

BRISBANE, Calif, Feb. 07, 2018 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq:CDNA), a molecular diagnostics company focused on the discovery, development and commercialization of clinically differentiated, high-value diagnostic solutions for transplant patients, today announced that Peter Maag, Chief Executive Officer, and Michael Bell, Chief Financial Officer, will be participating in four upcoming investor conferences.

Leerink Partners 7th Annual Global Healthcare Conference in New York City

BTIG Healthcare Conference in Snowbird, Utah

30th Annual Roth Conference in Laguna Niguel, California

H. C. Wainwright Global Life Sciences Conference in Monte Carlo, Monaco

A live audio webcast of the H. C. Wainwright Global Life Sciences Conference will be available online from the investor relations section of the CareDx website at http://investors.caredx.com. The webcast replay of the presentation will be available approximately one hour following the conclusion of the live presentation and will be available on the Company's website for 90 days. Management will be hosting one-on-one meetings for the Leerink Partners 7th Annual Global Healthcare Conference, the BTIG Healthcare Conference and the 30th Annual Roth Conference and no webcasts will be available for these events.

About CareDx
CareDx, Inc., headquartered in Brisbane, California, is a molecular diagnostics company focused on the discovery, development and commercialization of clinically differentiated, high-value diagnostic solutions for transplant recipients. CareDx offers products across the transplant testing continuum, including AlloMap® and AlloSure™ for post-transplant surveillance and Olerup SSP®, Olerup QTYPE®, and Olerup SBT™ for pre-transplant HLA testing.

For more information, please visit: www.CareDx.com.

CONTACTS:

CareDx, Inc.
Sasha King
Chief Commercial Officer
415-287-2393
sking@caredx.com

Investor Relations
David Clair
Integrated Corporate Relations, Inc.
646-277-1266
david.clair@icrinc.com

Primary Logo

Source: CareDx, Inc.

News Provided by Acquire Media